|
C9ORF64 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.247400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.900360E-02 |
| Normal-vs-Stage2 |
8.603200E-01 |
| Normal-vs-Stage3 |
5.723700E-03 |
| Normal-vs-Stage4 |
6.858300E-02 |
| Stage1-vs-Stage2 |
2.646200E-01 |
| Stage1-vs-Stage3 |
1.87332999999068E-05 |
| Stage1-vs-Stage4 |
1.335140E-03 |
| Stage2-vs-Stage3 |
5.041600E-02 |
| Stage2-vs-Stage4 |
1.525570E-01 |
| Stage3-vs-Stage4 |
6.156200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.482200E-01 |
| Normal-vs-AfricanAmerican |
2.677800E-02 |
| Normal-vs-Asian |
2.743400E-01 |
| Caucasian-vs-AfricanAmerican |
3.443800E-02 |
| Caucasian-vs-Asian |
1.383180E-01 |
| AfricanAmerican-vs-Asian |
2.028300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.162000E-01 |
| Normal-vs-Female |
7.463800E-01 |
| Male-vs-Female |
5.358000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.513200E-01 |
| Normal-vs-Age(41-60Yrs) |
4.845600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.704200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.140200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.182200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.607400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.983800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.072000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.290800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.127800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.490100E-02 |
| Normal-vs-Grade 2 |
1.401520E-02 |
| Normal-vs-Grade 3 |
4.924200E-01 |
| Normal-vs-Grade 4 |
4.68129999997569E-06 |
| Grade 1-vs-Grade 2 |
3.610400E-01 |
| Grade 1-vs-Grade 3 |
4.875700E-02 |
| Grade 1-vs-Grade 4 |
3.426600E-04 |
| Grade 2-vs-Grade 3 |
5.435200E-03 |
| Grade 2-vs-Grade 4 |
9.43440003897678E-09 |
| Grade 3-vs-Grade 4 |
1.154530E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.74890000043315E-07 |
| Normal-vs-ccB subtype |
3.61309999999948E-05 |
| ccA subtype-vs-ccB subtype |
3.44169137633799E-15 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.647200E-01 |
| Normal-vs-N1 |
2.911800E-01 |
| N0-vs-N1 |
2.262000E-01 |
|
|
